Profile data is unavailable for this security.
About the company
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
- Revenue in CAD (TTM)21.76m
- Net income in CAD-1.16m
- Incorporated2000
- Employees25.00
- LocationMedicure Inc1250 Waverley StreetWINNIPEG R3T 6C6CanadaCAN
- Phone+1 (204) 487-7412
- Fax+1 (204) 487-7412
- Websitehttps://www.medicure.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Indiva Ltd | 37.49m | -4.44m | 8.80m | 142.00 | -- | -- | -- | 0.2347 | -0.0248 | -0.0248 | 0.2093 | -0.0066 | 0.9948 | 6.15 | 8.59 | -- | -11.77 | -29.67 | -39.98 | -48.24 | 29.21 | 20.37 | -11.83 | -48.06 | 0.4471 | -0.4265 | 1.06 | -- | 9.21 | 264.60 | 55.01 | -- | -33.00 | -- |
| Voyageur Pharmaceuticals Ltd | 0.00 | -1.35m | 9.03m | -- | -- | 5.73 | -- | -- | -0.0101 | -0.0101 | 0.00 | 0.0114 | 0.00 | -- | -- | -- | -50.78 | -74.47 | -69.30 | -120.92 | -- | -- | -- | -- | 0.4715 | -290.54 | 0.0248 | -- | -- | -- | 20.21 | -- | -11.81 | -- |
| Khiron Life Sciences Corp | 16.14m | -30.66m | 9.30m | 310.00 | -- | 0.3205 | -- | 0.5761 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
| Valeo Pharma Inc | 54.29m | -28.43m | 9.37m | 100.00 | -- | -- | -- | 0.1727 | -0.3255 | -0.3255 | 0.6249 | -0.4765 | 1.23 | 3.53 | 12.39 | 434,296.00 | -64.52 | -64.35 | -215.78 | -113.22 | 21.38 | 23.88 | -52.37 | -69.71 | 0.2974 | -1.33 | 3.51 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
| Medicure Inc | 21.76m | -1.16m | 10.44m | 25.00 | -- | 0.509 | 10.30 | 0.4796 | -0.1122 | -0.1122 | 2.02 | 1.96 | 0.7499 | 2.52 | 4.11 | 870,400.00 | -4.00 | -13.42 | -5.46 | -18.28 | 64.75 | 61.87 | -5.33 | -27.38 | 1.59 | -- | 0.0227 | -- | -5.94 | -5.71 | -167.55 | -- | -28.82 | -- |
| CanadaBis Capital Inc | 20.91m | 3.27m | 11.73m | -- | 3.59 | 1.44 | 2.90 | 0.561 | 0.0237 | 0.0237 | 0.1514 | 0.0592 | 0.9778 | 1.90 | 9.81 | -- | 15.27 | -20.55 | 27.30 | -54.86 | 52.50 | -- | 15.62 | -26.61 | 0.5509 | 7.88 | 0.4948 | -- | 90.44 | -- | 630.61 | -- | 238.08 | -- |
| Delivra Health Brands Inc | 12.11m | -711.00k | 12.50m | -- | -- | 3.51 | 20.63 | 1.03 | -0.0026 | -0.0026 | 0.0426 | 0.0114 | 1.23 | 2.50 | 7.19 | -- | -7.25 | -45.81 | -14.01 | -58.34 | 55.93 | 37.95 | -5.87 | -289.55 | 1.50 | 0.0091 | 0.3613 | -- | 20.30 | 68.26 | 97.37 | -- | -56.72 | -- |
